Does Rallies show 13F holders for MMED?

Yes. Rallies tracks hedge fund and 13F ownership data for MMED, including fund names, share counts, latest tracked quarter, and position changes when available.

Is MMED research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MMED. It does not provide personalized investment advice.

MMED (MiniMed Group, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

MiniMed Group, Inc. Common Stock (MMED) is a publicly traded the market company. As of May 21, 2026, MMED trades at $11.63 with a market cap of $3.06B and a P/E ratio of 0.00. MMED moved +6.98% today. Year to date, MMED is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $10.65 to $20.48. Analyst consensus is strong buy with an average price target of $20.85. Rallies surfaces MMED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns MMED stock?

Hedge funds tracked by Rallies that own MMED include Sculptor Capital, Bluecrest Capital, and Chilton Investment. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MiniMed Group, Inc. Common Stock.

MMED Key Metrics

Key financial metrics for MMED
Metric	Value
Price	$11.63
Market Cap	$3.06B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$20.48
52-Week Low	$10.65
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding MMED

Sculptor Capital holds 306.00K shares of MMED, changed +0.00% as of Mar 31, 2026.
Bluecrest Capital holds 275.00K shares of MMED, changed +0.00% as of Mar 31, 2026.
Chilton Investment holds 55.50K shares of MMED, changed +0.00% as of Mar 31, 2026.

Latest MMED News

MiniMed Secures Canadian License for Simplera Sync Sensor and Type 2 Indication — Apr 28, 2026
MiniMed Gains FDA Clearance for Half-Size Flex Pump with 300-Unit Reservoir — Mar 18, 2026
MiniMed Raises $538M in 28M Share IPO at $20, Medtronic Retains 90% — Mar 9, 2026
MiniMed launches Nasdaq Global Select IPO as second-largest Medtech offering — Mar 6, 2026

Recent MMED Insider Trades

Torbert Hank bought 10 (~$3.8) on Apr 24, 2013.
Torbert Hank bought 20 (~$29) on Mar 20, 2012.
Kachidza Johnson M bought 50.00K (~$250.00K) on Feb 22, 2010.

MMED Analyst Consensus

13 analysts cover MMED: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.85.

Common questions about MMED

Who owns MMED stock?: Hedge funds tracked by Rallies that own MMED include Sculptor Capital, Bluecrest Capital, and Chilton Investment. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MiniMed Group, Inc. Common Stock.
Does Rallies show 13F holders for MMED?: Yes. Rallies tracks hedge fund and 13F ownership data for MMED, including fund names, share counts, latest tracked quarter, and position changes when available.
Is MMED research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MMED. It does not provide personalized investment advice.